Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on August 26, 2026

The Foundation Behind TGC Capital Partners - Gateway Group, Reflects on 29 Years of Building Global Businesses
PeriodTools Publishes Free Cycle and Ovulation Calculators; Its Period Tracker Stores Entries in the Browser
System‑wide Insights via a Single Sample:Cloud‑Clone CBA Ushers in a New Era for Neuro‑Endocrine‑Immune Network Research
Creative Biolabs Advances circRNA Research from Analysis to Delivery
Fly IT Solution Launches HealthSync, a White-Label Homecare Management Platform
Alerte Digital Vet to present and exhibit at The VET Expo 2026
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
Eikon Therapeutics to Participate in Investor Conferences in September 2026
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
Ligand to Participate in September Investor Conferences
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
Optical Sorter Global Market to Reach $5.4 Billion by 2030, Driven by AI-Powered Sorting Systems and Circular Economy Mandates
HepaRegeniX Receives Orphan Drug Designation for Darizmetinib for the Prevention of Post-Hepatectomy Liver Failure
Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer's Cognition

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.